Medical Research
Deep Bio: Three posters will be presented at the AACR Annual Meeting 2024 to spotlight Deep Bio's pioneering research and advancements in AI within digital pathology SEOUL, SOUTH KOREA, March 28, 2024 /EINPresswire.com/ -- Deep Bio, a...
Ibex: Studies to Be Presented at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting Brigham and Women's Hospital and Champalimaud Foundation research shows high accuracy levels of Galen Breast in identifying...
ORNL: Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer. In partnership with the National Cancer Institute, or NCI, researchers from the Department of Energy’s Oak Ridge National...
Lunit: A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint...
Read the latest publication from RareCyte. Journal of Clinical Oncology: Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)1 ICI therapy Understanding the mechanisms of acquired resistance...
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by...
